Zeo ScientifiX (ZEOX) Cash & Equivalents Growth (1y) (2014 - 2026)
Zeo ScientifiX (ZEOX) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 23.56% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.05% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 71.81% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 34.71% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 84.98% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.39% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -14.35% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -57.58% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 28.50% |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 240.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 240.59% |
| Jan 31, 2026 | 43.06% |
| Oct 31, 2025 | -66.36% |
| Jul 31, 2025 | -77.38% |
| Apr 30, 2025 | -27.35% |
| Jan 31, 2025 | -38.57% |
| Oct 31, 2024 | -62.59% |
| Jul 31, 2024 | 74.57% |
| Apr 30, 2024 | -34.04% |
| Jan 31, 2024 | -17.58% |
| Oct 31, 2023 | -53.21% |
| Jul 31, 2023 | 747.79% |
| Apr 30, 2023 | 1,613.58% |
| Jan 31, 2023 | 845.98% |
| Oct 31, 2022 | 3,356.76% |
| Jul 31, 2022 | 155.64% |
| Apr 30, 2022 | -66.31% |
| Jan 31, 2022 | 124.98% |
| Oct 31, 2021 | -81.62% |
| Jul 31, 2021 | -90.78% |